Skip to main content Skip to main menu
UF Health University of Florida
College of Pharmacy UNIVERSITY of FLORIDA
Kathryn E DeSear

Kathryn E DeSear, Pharm.D.

Clinical Associate Professor

Department: Pharmacy Education and Practice
Business Phone: (352) 273-6236
Business Email: katysa33@ufl.edu
CV: View Curriculum Vitae

About Kathryn E DeSear

Kate DeSear, Pharm.D., BCIDP, FIDSA, is an associate professor in the Department of Pharmacy Education and Practice in the University of Florida College of Pharmacy. She maintains a practice site as a clinical specialist in infectious diseases at UF Health Shands Hospital, an 1,162 bed academic medical center, and co-leads the antimicrobial stewardship program. She serves as the residency program director of the Infectious Diseases PGY-2 residency.

DeSear received her Doctor of Pharmacy degree from the University of Florida. She completed her pharmacy practice residency at Bay Pines Veterans Affairs Hospital and a specialty residency in infectious diseases at the UF Health Shands Hospital. Her areas of interest include antimicrobial stewardship, novel stewardship measures relating antimicrobial use to clinical and process outcomes, and gram negative resistance.

She is an active member of IDSA, serving previously on the Recognitions and Awards Committee; and an active member of the Society of Infectious Diseases Pharmacists, serving in many leadership roles including past treasurer of the society.

Board Certifications

  • Board Certified Infectious Diseases Pharmacist
    BPS

Clinical Profile

Areas of Interest
  • Infectious Diseases

Publications

Academic Articles
2025
Effectiveness of ceftazidime-avibactam versus ceftolozane-tazobactam for multidrug-resistant Pseudomonas aeruginosa infections in the USA (CACTUS): a multicentre, retrospective, observational study.
The Lancet. Infectious diseases. 25(5):574-584 [DOI] 10.1016/S1473-3099(24)00648-0. [PMID] 39701120.
6 citations · PubMed · Publisher’s Site
2025
Impact of Timing of Beta-Lactam Therapeutic Drug Monitoring and Therapy Adjustment in Critically Ill Patients.
Antibiotics (Basel, Switzerland). 14(5) [DOI] 10.3390/antibiotics14050463. [PMID] 40426530.
PubMed · Publisher’s Site
2024
Association of piperacillin and vancomycin exposure on acute kidney injury during combination therapy.
JAC-antimicrobial resistance. 6(1) [DOI] 10.1093/jacamr/dlad157. [PMID] 38259903.
2 citations · PubMed · Publisher’s Site
2024
Bridging Echinocandin With Azole Antifungal Therapy on Prevention of Invasive Candidiasis Post-Lung Transplantation.
Open forum infectious diseases. 11(9) [DOI] 10.1093/ofid/ofae525. [PMID] 39329111.
PubMed · Publisher’s Site
2024
Brincidofovir for disease progression due to suspected tecovirimat resistance in association with advanced HIV.
International journal of STD & AIDS. 35(8):651-653 [DOI] 10.1177/09564624241238813. [PMID] 38502040.
4 citations · PubMed · Publisher’s Site
2023
A 40-Year-Old Female With Mycobacterium abscessus Successfully Treated With a Dual Beta-Lactam Combination.
Cureus. 15(6) [DOI] 10.7759/cureus.40993. [PMID] 37503487.
9 citations · PubMed · Publisher’s Site
2023
Re-evaluation of cefepime or piperacillin/tazobactam to decrease use of carbapenems in ESBL-producing Enterobacterales urinary tract infections (REDUCE-UTI).
JAC-antimicrobial resistance. 5(2) [DOI] 10.1093/jacamr/dlad021. [PMID] 36936190.
7 citations · PubMed · Publisher’s Site
2022
Implementation of a β-lactam therapeutic drug monitoring program: Experience from a large academic medical center.
American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists. 79(18):1586-1591 [DOI] 10.1093/ajhp/zxac171. [PMID] 35704702.
11 citations · PubMed · Publisher’s Site
2022
Re-evaluation of cefepime or piperacillin-tazobactam to decrease use of carbapenems in extended-spectrum beta-lactamase–producing Enterobacterales bloodstream infections (REDUCE-BSI)
Antimicrobial Stewardship & Healthcare Epidemiology. 2(1) [DOI] 10.1017/ash.2022.21. [PMID] 36310806.
7 citations · PubMed · Publisher’s Site
2022
Resource Over-Utilization in Hospitalized Patients With Uncomplicated Skin and Soft Tissue Infections.
Journal of pharmacy practice. 35(5):675-679 [DOI] 10.1177/08971900211000216. [PMID] 33752488.
1 citation · PubMed · Publisher’s Site
2021
Dissemination mechanisms of NDM genes in hospitalized patients.
JAC-antimicrobial resistance. 3(1) [DOI] 10.1093/jacamr/dlab032. [PMID] 34223104.
10 citations · PubMed · Publisher’s Site
2021
Draft Genome Sequence of a Burkholderia cepacia Complex Strain Isolated from a Human Intra-abdominal Abscess.
Microbiology resource announcements. 10(11) [DOI] 10.1128/MRA.00091-21. [PMID] 33737360.
1 citation · PubMed · Publisher’s Site
2016
A HAART-Breaking Review of Alternative Antiretroviral Administration: Practical Considerations with Crushing and Enteral Tube Scenarios.
Pharmacotherapy. 36(11):1145-1165 [DOI] 10.1002/phar.1835. [PMID] 27636237.
20 citations · PubMed · Publisher’s Site

Grants

May 2021 – Jul 2024
Prevalence of Cefazolin Inoculum Effect in Mcthicillin Susceptible Staphylococcus aureus Bacteremia
Role: Co-Investigator
Funding: UF HEALTH SHANDS HOSPITAL

Education

PharmD
2011 · University of Florida

Contact Details

Phones:
Business:
(352) 273-6236
Emails:
Business:
katysa33@ufl.edu
Addresses:
Business Mailing:
PO Box 100486
 GAINESVILLE FL 32610
Business Street:
1225 CENTER DR
 GAINESVILLE FL 32610